Ticker

Senestech, Inc. (NASDAQ: SNES - Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totaling 31,028 shares, a growth of 59.2% from the March 31st total of 19,492 shares. Currently, 0.6% of the shares of the stock are short sold. Based on

RBC Life Sciences (OTCMKTS:RBCL - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation. Volatility and Risk RBC Life Sciences has a

Senestech, Inc. (NASDAQ: SNES - Get Free Report) saw a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 49,411 shares, a growth of 127.9% from the February 12th total of 21,680 shares. Based on an average daily volume of 72,794 shares, the days-to-cover ratio is

SenesTech, Inc. (SNES) Q4 2025 Earnings Call Transcript

SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025.